CTOs on the Move

Clinical Automated Office Solutions / CAOS

www.ecaos.com

 
Clinical Automated Office Solutions / CAOS is a Winston Salem, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ecaos.com
  • 1590 Westbrook Plaza Dr Ste 101
    Winston Salem, NC USA 27103
  • Phone: 877.833.7570

Executives

Name Title Contact Details

Similar Companies

OneWorld

OneWorld provides quality affordable health care, and individuals are welcome with or without insurance, including Medicaid and Medicare. OneWorld operates 13 clinical locations in Omaha; including the clinics at the Historic Livestock Exchange Campus, OneWorld West, Northwest Omaha, Cass Family Medicine, OneWorld Bellevue, Crossroads to Health and Recovery at Community Alliance, two mobile dental clinics, four school-based health centers and the South Omaha Learning Community Centers. Established in 1970, OneWorld Community Health Centers, in partnership with the community, provides culturally respectful, quality health care with special attention to the underserved. OneWorld is a federally qualified health center (FQHC) and provides comprehensive primary health care, dental, mental health/ substance abuse services, and affordable medications.

Patient First

Patient First is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Quilleer and Blake Advertising

Quilleer and Blake Advertising is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ScienceBased Health

ScienceBased Health is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.